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CT Abdomen W/WO Contrast Findings
• Started on D10 drip
• Given psych history, concern for surreptitious use 
of insulin 
• Persistently hypoglycemic for days  work up
Work Up
• Fasting insulin 163 ↑
• C-peptide 7.0 ↑
• Cortisol, TSH normal
• 72-hour fast: gold standard for diagnosis 
• see table 
• Pancreas CT protocol: 
• 4 cm mass in pancreatic tail 
• With multiple hyper-vascular 
heterogeneously enhancing 
hepatic masses, largest 9 cm
• Pathology: metastatic well-differentiated 
neuroendocrine tumor grade 3, stage IV with bi-
lobar liver metastases. 
Treatment
• NOT candidate for surgery
• Diazoxide: reduces insulin secretion
• Octreotide 200 mcg TID 
• Y90 therasphere radio-embolization to left + right 
hepatic lobar tumors 
• Continued on Octreotide injection q4 weeks 
lifelong
• Insulinoma: 1-4 cases/million/year; very rare. 
• Causes hyperinsulinemic hypoglycemia
• diaphoresis, tremors, personality 
changes, seizures. 
• 90% benign
• Malignant insulinomas: extremely rare
• Invade into soft tissue, lymph node, 
liver. 
• Unresectable; require targeted 
therapy.
• 5% of insulinomas associated with MEN1  
DIAGNOSIS
TREATMENT
• #1 Surgical resection: curative 
• Other: 
• Injection of octreotide
• EUS-aided alcohol ablation
• Radio-frequency ablation or 
embolization
• Targeted therapy: everolimus or sunitinib
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A 49-year-old female with Huntington’s disease 
presents to the ED after being found unresponsive
at her assisted-living facility. 
History of Present Illness
• Hypoglycemic, glucose 21, responsive to 
dextrose. Refused admission
• Other symptoms: dizziness, tremors, nausea; 
attributed to her psychiatric condition. 
• Symptoms re-occurred, admitted.
• No other medical history. 
• Only medication: Zyprexa
Exam
• Afebrile, pulse 102, BP 112/69, RR 18, SpO2 
100% RA
• General: Young adult female, anxious, frequent 
spastic, choreioform movements. 
• Abdomen: No abdominal masses palpable. 
• Neuro: Poor coordination. 
• We present a 49 YO patient with severe persistent 
hypoglycemia believed to be from surreptitious 
use of insulin given her underlying psychiatric 
disease but ultimately diagnosed with a metastatic 
insulinoma. 
• Diagnosis often delayed or missed; 
• symptoms attributed to psychiatric, 
cardiac, neurological disorders. 
• Missed diagnosis can be fatal, deprives patient of 
curative treatment. 
• Severe hypoglycemia not always due to 
medication overuse or misuse.
• Must evaluate for further causes of hypoglycemia 
such as insulinoma as this can save a patient’s 
life.
72-Hour Fasting Protocol Results
Lab value Result Diagnosis of Insulinoma
Glucose 23 < 45
Insulin 101 ↑↑ Inappropriately elevated
C-Peptide 4.1 ↑ Inappropriately elevated
Pro-insulin 782 ↑↑ <8.0
Insulin/C-peptide ratio 0.25 <1.0
Beta-hydroxybutyrate
(ketones)
Undetected <2.7
Insulinoma
Clinical:       Whipple’s triad
1. Hypoglycemia; glucose <50 mg/dL
2. Neuroglycopenic symptoms 
3. Relief with administering glucose
Gold Standard:  72-Hour Fasting Protocol
• Measure insulin, C-peptide, pro-
insulin, ketones, glucose, ratio
• Detects 99% of insulinomas
Imaging:  Abdominal CT, MRI, EUS
